137 related articles for article (PubMed ID: 16515587)
1. Fas gene promoter -670 polymorphism in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Int J Gynecol Cancer; 2006; 16 Suppl 1():179-82. PubMed ID: 16515587
[TBL] [Abstract][Full Text] [Related]
2. Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population.
Kordi Tamandani DM; Sobti RC; Shekari M
Clin Exp Obstet Gynecol; 2008; 35(3):183-6. PubMed ID: 18754288
[TBL] [Abstract][Full Text] [Related]
3. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis.
Ueda M; Hung YC; Terai Y; Yamaguchi H; Saito J; Nunobiki O; Noda S; Ueki M
Gynecol Oncol; 2005 Jul; 98(1):129-33. PubMed ID: 15894356
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
Chen X; Mo W; Peng Q; Su X
BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
[TBL] [Abstract][Full Text] [Related]
6. Association between FAS A670G polymorphism and susceptibility to cervical cancer: evidence from a meta-analysis.
Shen J; Sun NX
Tumour Biol; 2013 Dec; 34(6):3443-8. PubMed ID: 23900676
[TBL] [Abstract][Full Text] [Related]
7. Murine double-minute 2 homolog single nucleotide polymorphism 309 and the risk of gynecologic cancer.
Ueda M; Yamamoto M; Nunobiki O; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
Hum Cell; 2009 May; 22(2):49-54. PubMed ID: 19379464
[TBL] [Abstract][Full Text] [Related]
8. FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer.
Kang S; Dong SM; Seo SS; Kim JW; Park SY
Cancer Genet Cytogenet; 2008 Jan; 180(1):1-5. PubMed ID: 18068525
[TBL] [Abstract][Full Text] [Related]
9. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
10. Fas/CD95 promoter polymorphism gene and its relationship with cervical carcinoma.
Zucchi F; da Silva ID; Ribalta JC; de Souza NC; Speck NM; Girão MJ; Brenna SM; Syrjänen KJ
Eur J Gynaecol Oncol; 2009; 30(2):142-4. PubMed ID: 19480241
[TBL] [Abstract][Full Text] [Related]
11. FAS-670A/G polymorphism: A biomarker for the metastasis of nasopharyngeal carcinoma in a Chinese population.
Zhu Q; Wang T; Ren J; Hu K; Liu W; Wu G
Clin Chim Acta; 2010 Feb; 411(3-4):179-83. PubMed ID: 19895798
[TBL] [Abstract][Full Text] [Related]
12. FAS c.-671A>G polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Tan SC; Ismail MP; Duski DR; Othman NH; Ankathil R
Cancer Genet; 2017 Feb; 211():18-25. PubMed ID: 28279307
[TBL] [Abstract][Full Text] [Related]
13. FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.
Zhong-Xing Z; Yuan-Yuan M; Hai Zhen M; Jian-Gang Z; Li-Feng Z
PLoS One; 2013; 8(8):e73700. PubMed ID: 24014103
[TBL] [Abstract][Full Text] [Related]
14. The association between -1304T>G polymorphism in the promoter of mitogen-activated protein kinase kinase 4 gene and the risk of cervical cancer in Chinese population.
Hu M; Zheng J; Zhang L; Jiang L; You Y; Jiang M; Li H
DNA Cell Biol; 2012 Jul; 31(7):1167-73. PubMed ID: 22335172
[TBL] [Abstract][Full Text] [Related]
15. The Correlation Between TNF-α Promoter Gene Polymorphism and Genetic Susceptibility to Cervical Cancer.
Li X; Yin G; Li J; Wu A; Yuan Z; Liang J; Sun Q
Technol Cancer Res Treat; 2018 Jan; 17():1533033818782793. PubMed ID: 29940817
[TBL] [Abstract][Full Text] [Related]
16. The role of FAS gene variants in inflammatory bowel disease.
Demir A; Kahraman R; Candan G; Ergen A
Turk J Gastroenterol; 2020 May; 31(5):356-361. PubMed ID: 32519954
[TBL] [Abstract][Full Text] [Related]
17. Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.
Chen Y; Wang H; Yan Y; Ren M; Yan C; Wang B
Medicine (Baltimore); 2019 Dec; 98(49):e18240. PubMed ID: 31804351
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphism of PIN1 rs2233679 is associated with the progression of CIN to early cervical cancer in Hunan Chinese.
Wang K; Fan J; Lin W; Zou C; He M; Cai Y; Pei H; Li M
Taiwan J Obstet Gynecol; 2020 Mar; 59(2):220-226. PubMed ID: 32127141
[TBL] [Abstract][Full Text] [Related]
19. No evidence of the involvement of the Fas -670 promoter polymorphism in cervical cancer in situ.
Engelmark MT; Renkema KY; Gyllensten UB
Int J Cancer; 2004 Dec; 112(6):1084-5. PubMed ID: 15316939
[No Abstract] [Full Text] [Related]
20. Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population.
Zhao QM; Guo X; Lai JH; Tan WH; Wang WZ; Dang XQ
Clin Rheumatol; 2012 Jul; 31(7):1051-7. PubMed ID: 22431252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
